These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)? Spechler SJ Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402 [TBL] [Abstract][Full Text] [Related]
23. Endoscopic ablative therapy for Barrett's esophagus: a potential cause of eosinophilic esophagitis. Owens VL; Katzka DA; Lutzke LS; Wang KK; Smyrk TC Dis Esophagus; 2012 Jan; 25(1):33-9. PubMed ID: 21668572 [TBL] [Abstract][Full Text] [Related]
24. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Schembre DB; Huang JL; Lin OS; Cantone N; Low DE Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860 [TBL] [Abstract][Full Text] [Related]
26. Endoscopic therapy of esophageal premalignancy and early malignancy. Nealis TB; Washington K; Keswani RN J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219 [TBL] [Abstract][Full Text] [Related]
27. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Fayter D; Corbett M; Heirs M; Fox D; Eastwood A Health Technol Assess; 2010 Jul; 14(37):1-288. PubMed ID: 20663420 [TBL] [Abstract][Full Text] [Related]
28. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus. Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393 [TBL] [Abstract][Full Text] [Related]
30. Molecular evaluation of ablative therapy of Barrett's oesophagus. Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364 [TBL] [Abstract][Full Text] [Related]
31. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. van den Boogert J; van Hillegersberg R; Siersema PD; de Bruin RW; Tilanus HW Am J Gastroenterol; 1999 May; 94(5):1153-60. PubMed ID: 10235186 [TBL] [Abstract][Full Text] [Related]
32. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia. Overholt BF Am J Manag Care; 2000 Oct; 6(16 Suppl):S903-8. PubMed ID: 11184664 [TBL] [Abstract][Full Text] [Related]
33. Barrett's oesophagus: optimal strategies for prevention and treatment. Fass R; Sampliner RE Drugs; 2003; 63(6):555-64. PubMed ID: 12656653 [TBL] [Abstract][Full Text] [Related]
34. Ablation of Barrett's mucosa. Sampliner RE Gastroenterologist; 1997 Sep; 5(3):185-8. PubMed ID: 9298373 [TBL] [Abstract][Full Text] [Related]
35. Effect of antireflux surgery for Barrett's esophagus: long-term results. Rayner CJ; Gatenby P Minerva Chir; 2016 Jun; 71(3):180-91. PubMed ID: 26976731 [TBL] [Abstract][Full Text] [Related]
36. [Argon plasma coagulation in Barrett's esophagus]. Nomura T; Yamashita K; Miyashita M; Tajiri T Nihon Rinsho; 2005 Aug; 63(8):1458-62. PubMed ID: 16101240 [TBL] [Abstract][Full Text] [Related]
37. Medical therapy versus antireflux surgery in Barrett's esophagus: what is the best therapeutic approach? Klaus A; Hinder RA Dig Dis; 2000-2001; 18(4):224-31. PubMed ID: 11356994 [TBL] [Abstract][Full Text] [Related]
38. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Sampliner RE; Camargo L; Fass R Am J Gastroenterol; 2002 Feb; 97(2):270-2. PubMed ID: 11866260 [TBL] [Abstract][Full Text] [Related]